• Iptacopan (LNP023): From C3bBb to Clinical Signal

  2026-09-10

  Iptacopan (LNP023) offers a translational route from selective factor B blockade to measurable control of complement-driven hemolysis. This article connects molecular mechanism, assay interpretation, animal evidence, and the pivotal PNH proof-of-concept findings to guide better complement activation research.

• BMS 309403: FABP4 Inhibitor Workflow

  2026-09-10

  BMS 309403 enables targeted testing of FABP4-dependent lipid handling, macrophage inflammation, and foam-cell formation. This workflow connects cell-based dose–response experiments with SERCA2–CaN–FoxO1 pathway analysis and translational atherosclerosis models.

• Cy5 Goat Anti-Mouse IgG for Exosome Assays

  2026-09-09

  Discover how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody can support mechanism-focused exosome and osteogenesis assays. This guide connects fluorescent detection strategy, assay controls, and lithium-driven Wnt10a research without confusing signal enhancement with mechanistic proof.

• Fosinopril Sodium: ACE Inhibitor Research Guide

  2026-09-09

  Fosinopril sodium is an oral prodrug ACE inhibitor that is hydrolyzed to fosinoprilat and used to study blood pressure, cardiac, and renal endpoints. Its reported 9 nM ACE-inhibition potency, phosphinic acid zinc-ion interaction, and renal-hepatic elimination profile support hypertension research while requiring careful assay and formulation controls.

• Methoxy-X04 Workflows for Amyloid Imaging

  2026-09-08

  Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe for connecting plaque burden, soluble aggregates, and microglial responses in Alzheimer’s disease models. This practical guide covers preparation, in vivo timing, tissue workflows, rTMS-related assay design, and troubleshooting for more reproducible amyloid imaging.

• Cimetidine in BBB and GI Cancer Research

  2026-09-07

  Cimetidine provides a practical way to connect H2 receptor biology with gastrointestinal cancer assays and exploratory barrier-permeability studies. This guide combines product-handling advice, Transwell workflow design, lysosomal-trapping controls, and troubleshooting for more interpretable research data.

• Methoxy-X04 Workflow for Amyloid Imaging

  2026-09-07

  Learn how to deploy Methoxy-X04 as a brain-permeable fluorescent amyloid beta probe for plaque, oligomer, and vascular amyloid studies. The workflow connects rapid in vivo imaging with exercise-induced extracellular-vesicle research and provides practical controls for reproducible quantification.

• Targeted Nano-Delivery for P. aeruginosa Wounds

  2026-09-05

  The 2025 Materials Today Bio study developed Apt-pM@UCNPmSiO2-Cur-CAZ, a targeted nanodelivery system combining a pretreated macrophage membrane, an aptamer, curcumin, ceftazidime, and upconversion nanoparticles. The construct improved antibacterial and antibiofilm activity, particularly under near-infrared irradiation, and promoted healing in a mouse model of Pseudomonas aeruginosa-infected wounds without evident major toxicity.

• Dimetridazole Disarms P. aeruginosa Virulence

  2026-09-05

  The reference study identified Dimetridazole and Ribavirin as antivirulence candidates that weaken Pseudomonas aeruginosa quorum sensing, reduce virulence-associated phenotypes, and improve the activity of selected antibiotics. Its combination of phenotypic assays, transcriptomics, gene-expression validation, drug synergy testing, and infection models provides a useful framework for evaluating quorum sensing inhibition beyond direct bacterial killing.

• Acetylcysteine in PDAC Co-Culture Assays

  2026-09-04

  Acetylcysteine can help interrogate redox-dependent behavior in patient-derived pancreatic cancer organoid–fibroblast models. This guide explains how to distinguish genuine oxidative stress pathway modulation from assay interference, stromal protection, or altered drug exposure.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-09-04

  The 2025 reference study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, foam-cell assays, Smart-seq analysis, and macrophage-specific RXRα knockdown provides a mechanistic framework for studying inflammatory aging in vascular disease.

• GCRV104 Entry and Clathrin-Mediated Endocytosis

  2026-09-03

  Wang et al. used complementary pharmacological, ultrastructural, and molecular assays to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, acidification-dependent clathrin-mediated pathway. The study provides a mechanistic framework for distinguishing viral entry routes and identifies endosomal acidification, dynamin, PI3K, and protein kinase C as experimentally relevant points for further investigation.

• 5X Protein Loading Buffer (Reducing) Guide

  2026-09-02

  5X Protein Loading Buffer (Reducing) supports protein sample preparation for conventional denaturing SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and bromophenol blue. It is intended for reducing workflows and should not be used when native structure, intact disulfide bonds, or non-reducing conditions must be preserved.

• Spiroplasma eriocheiris Entry into Drosophila S2 Cells

  2026-09-02

  Wei et al. established a Drosophila Schneider 2 cell model to show that Spiroplasma eriocheiris invades insect cells through clathrin-dependent endocytosis and macropinocytosis, with support from actin filaments and microtubules. The study combines infection phenotyping, intracellular bacterial quantification, pathway inhibitors, and cytoskeletal perturbation to provide a mechanistic framework for studying a crustacean pathogen in an invertebrate cell system.

• HNF4A-AS1 and Sorafenib Resistance in HCC

  2026-09-01

  A 2024 Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma. Its loss increases DECR1 expression, lowers intracellular polyunsaturated fatty acids, and supports drug resistance, linking epitranscriptomic regulation to lipid metabolic reprogramming.

7975 records 1/532 page Next 12345 下5页 Last page